Kamalesh K. Sankhala

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Sant P. Chawla, Arthur P. Staddon, Laurence H. Baker et al. · Journal of Clinical Oncology · 2011 · 246 citations · Full text

Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors

Razelle Kurzrock, N. Gabrail, Chandtip Chandhasin et al. · Molecular Cancer Therapeutics · 2011 · 168 citations

Neuro-oncology, Oncology, Brain Metastases +15

Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?

Emanuela Palmerini, Neal Shiv Chawla, Stefano Ferrari et al. · European Journal of Cancer · 2017 · 164 citations

Surgical Oncology, Tumoral Pathology, Malignant Disease +9

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer

Monica Mita, Anil A. Joy, Alain C. Mita et al. · Clinical Breast Cancer · 2013 · 151 citations

Advanced Breast Cancer, Breast Oncology, Oncology +8

First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma

Sant P. Chawla, Zsuzsanna Pápai, Guzel Mukhametshina et al. · JAMA Oncology · 2015 · 105 citations · Full text